Zobrazeno 1 - 10
of 208
pro vyhledávání: '"Katie A. Woods"'
Autor:
Aristides K. Maniatis, Ulhas Nadgir, Paul Saenger, Kent L. Reifschneider, Jennifer Abuzzahab, Larry Deeb, Larry A. Fox, Katie A. Woods, Wenjie Song, Meng Mao, Steven D. Chessler, Allison S. Komirenko, Aimee D. Shu, Samuel J. Casella, Paul S. Thornton
Publikováno v:
Hormone research in paediatrics. 95(3)
Introduction: The phase 3 fliGHt Trial evaluated the safety and tolerability of once-weekly lonapegsomatropin, a long-acting prodrug, in children with growth hormone deficiency (GHD) who switched from daily somatropin therapy to lonapegsomatropin. Me
Autor:
Aristides K Maniatis, Gail J. Mick, Aimee D Shu, David B Karpf, Wenjie Song, Mary Jennifer Abuzzahab, Larry Deeb, Larry A. Fox, Paul S. Thornton, Paul Saenger, Jessica M Peng, Katie A. Woods, Kent Reifschneider, Ulhas M Nadgir, Samuel J Casella
Publikováno v:
Journal of the Endocrine Society
Background: The Phase 3 fliGHt Trial evaluated children with growth hormone deficiency (GHD) of a broad range of baseline demographics and treatment durations who switched from daily growth hormone (hGH; somatropin) therapy to once-weekly TransCon hG
Autor:
Serge Amselem, L.B. Johnston, Adrian J. L. Clark, M. C. Postel-Vinay, M.O. Savage, Katie A. Woods
Growth hormone insensitivity (GHI) describes a group of disorders characterized by deficient biological action of GH. GH insensitivity may be of primary origin, that is, related to defects in genes coding for functional proteins essential for GH acti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::88f59b076de96a82fbfcd74440024d05
https://doi.org/10.1016/b978-0-12-801238-3.04123-4
https://doi.org/10.1016/b978-0-12-801238-3.04123-4
Publikováno v:
Reviews in Endocrine and Metabolic Disorders. 3:357-361
Autor:
Raymond M. Pace, Brian D. Frew, Hardayal S. Mehta, Hal Gustin, Anthony Giannuzzi, Katie E. Woods, Yuting Rui
Publikováno v:
Volume 6B: Materials and Fabrication.
During Refueling Outage 18 (RFO18, April 2011) Pilgrim Nuclear Power Station (PNPS) identified crack-like indications on the Steam Separator Lifting Lugs. A multi-disciplinary engineering effort was undertaken to determine the cause of the cracking a
Growth Hormone Insensitivity: Pathophysiology, Diagnosis, Clinical Variation and Future Perspectives
Autor:
Louise A. Metherell, Cecilia Camacho-Hübner, Christine P Burren, Adrian J. L. Clark, Joanne C. Blair, Katie A. Woods, Martin O. Savage
Publikováno v:
Hormone Research in Paediatrics. 55:32-35
The study of genetic growth hormone (GH) insensitivity is an evolving field. GH insensitivity syndrome (GHIS), otherwise known as Laron syndrome, is a heterogeneous disorder. Biochemical features consist of severe insulin-like growth factor I (IGF-I)
Autor:
Katie A. Woods, Martin O. Savage, Adrian J. L. Clark, Farideh Miraki-Moud, Cecilia Camacho-Hübner
Publikováno v:
Growth Hormone & IGF Research. 9:47-52
Insulin-like growth factor-I (IGF-I) is one of the most important regulator of growth. IGF-I deficiency is associated with prenatal and post-natal growth failure and may arise primarily as a result of GH receptor/post-receptor abnormalities or defect
Autor:
Ken K. Ong, Andrea Sherriff, Katie A. Woods, Marion L. Ahmed, Jean Golding, David B. Dunger, A. Watts
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 84:1145-1148
Recent discoveries of human genetic leptin deficiency have demonstrated its importance in regulating weight gain in early childhood. To investigate whether normal variation in leptin and insulin levels in cord blood could influence infancy growth, we
Publikováno v:
Acta Paediatrica. 88:158-162
Woods KA, Clark AJL, Amselem S, Savage MO. Relationship between phenotype and genotype in growth hormone insensitivity syndrome. Acta Paediatr 1999; Suppl 428: 158–62. Stockholm. ISSN 0803–5326 Growth hormone insensitivity syndrome (GHIS) of gene
Publikováno v:
Archives de Pédiatrie. 5:S364-S370
Le syndrome d'insensibilite a l'hormone de croissance (GHIS) est associe a de nombreuses mutations differentes du gene du recepteur de la GH et a une anomalie genetique nouvellement decrite du gene de l'IGF I. Nous avons etudie les caracteristiques p